Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia, but not pregnancies with small-for-gestational-age infants
- 31 January 2008
- journal article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 198 (1), 112.e1-112.e7
- https://doi.org/10.1016/j.ajog.2007.05.052
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Effects of prolonged oral supplementation with l‐arginine on blood pressure and nitric oxide synthesis in preeclampsiaEuropean Journal of Clinical Investigation, 2005
- Asymmetrical DimethylarginineCirculation, 2004
- Circulating Angiogenic Factors and the Risk of PreeclampsiaThe New England Journal of Medicine, 2004
- Asymmetric Dimethylarginine Causes Hypertension and Cardiac Dysfunction in Humans and Is Actively Metabolized by Dimethylarginine DimethylaminohydrolaseArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Practice bulletin #33: diagnosis and management of preeclampsia and eclampsiaObstetrics & Gynecology, 2002
- Fetal cerebral blood flow redistribution in late gestation: identification of compromise in small fetuses with normal umbilical artery DopplerUltrasound in Obstetrics & Gynecology, 2000
- Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial DysfunctionCirculation, 1998
- Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.JCI Insight, 1997
- Oxidative stress and preeclampsiaFetal and Maternal Medicine Review, 1997
- Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsiaThe Lancet, 1993